Literature DB >> 25617223

Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.

Christina A Christianson1, Nicholas P Goplen1, Iram Zafar1, Chaoyu Irvin1, James T Good2, Donald R Rollins2, Balachandra Gorentla1, Weimin Liu1, Magdalena M Gorska3, HongWei Chu4, Richard J Martin4, Rafeul Alam5.   

Abstract

BACKGROUND: Asthma in a mouse model spontaneously resolves after cessation of allergen exposure. We developed a mouse model in which asthma features persisted for 6 months after cessation of allergen exposure.
OBJECTIVE: We sought to elucidate factors contributing to the persistence of asthma.
METHODS: We used a combination of immunologic, genetic, microarray, and pharmacologic approaches to dissect the mechanism of asthma persistence.
RESULTS: Elimination of T cells though antibody-mediated depletion or lethal irradiation and transplantation of recombination-activating gene (Rag1)(-/-) bone marrow in mice with chronic asthma resulted in resolution of airway inflammation but not airway hyperreactivity or remodeling. Elimination of T cells and type 2 innate lymphoid cells (ILC2s) through lethal irradiation and transplantation of Rag2(-/-)γc(-/-) bone marrow or blockade of IL-33 resulted in resolution of airway inflammation and hyperreactivity. Persistence of asthma required multiple interconnected feedback and feed-forward circuits between ILC2s and epithelial cells. Epithelial IL-33 induced ILC2s, a rich source of IL-13. The latter directly induced epithelial IL-33, establishing a positive feedback circuit. IL-33 autoinduced, generating another feedback circuit. IL-13 upregulated IL-33 receptors and facilitated IL-33 autoinduction, thus establishing a feed-forward circuit. Elimination of any component of these circuits resulted in resolution of chronic asthma. In agreement with the foregoing, IL-33 and ILC2 levels were increased in the airways of asthmatic patients. IL-33 levels correlated with disease severity.
CONCLUSIONS: We present a critical network of feedback and feed-forward interactions between epithelial cells and ILC2s involved in maintaining chronic asthma. Although T cells contributed to the severity of chronic asthma, they were redundant in maintaining airway hyperreactivity and remodeling.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-33; T cells; Type 2 innate lymphoid cells; chronic asthma; feedback circuit

Mesh:

Substances:

Year:  2015        PMID: 25617223      PMCID: PMC4494983          DOI: 10.1016/j.jaci.2014.11.037

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  52 in total

1.  Building biological memory by linking positive feedback loops.

Authors:  Dong-Eun Chang; Shelly Leung; Mariette R Atkinson; Aaron Reifler; Daniel Forger; Alexander J Ninfa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

2.  Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells.

Authors:  Kazuyo Moro; Taketo Yamada; Masanobu Tanabe; Tsutomu Takeuchi; Tomokatsu Ikawa; Hiroshi Kawamoto; Jun-Ichi Furusawa; Masashi Ohtani; Hideki Fujii; Shigeo Koyasu
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

3.  Establishment of extracellular signal-regulated kinase 1/2 bistability and sustained activation through Sprouty 2 and its relevance for epithelial function.

Authors:  Weimin Liu; Kavita Tundwal; Qiaoling Liang; Nicholas Goplen; Sadee Rozario; Nayeem Quayum; Magdalena Gorska; Sally Wenzel; Silvana Balzar; Rafeul Alam
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

Review 4.  Asthma: clinical expression and molecular mechanisms.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

5.  Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma.

Authors:  Nicholas Goplen; M Zunayet Karim; Qiaoling Liang; Magdalena M Gorska; Sadee Rozario; Lei Guo; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

6.  CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling.

Authors:  Taylor A Doherty; Pejman Soroosh; David H Broide; Michael Croft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-05       Impact factor: 5.464

7.  Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells.

Authors:  David Préfontaine; Stéphane Lajoie-Kadoch; Susan Foley; Séverine Audusseau; Ron Olivenstein; Andrew J Halayko; Catherine Lemière; James G Martin; Qutayba Hamid
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

8.  Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.

Authors:  Weimin Liu; Qiaoling Liang; Silvana Balzar; Sally Wenzel; Magdalena Gorska; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2008-04       Impact factor: 10.793

9.  Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.

Authors:  Derek E Byers; Jennifer Alexander-Brett; Anand C Patel; Eugene Agapov; Geoffrey Dang-Vu; Xiaohua Jin; Kangyun Wu; Yingjian You; Yael Alevy; Jean-Philippe Girard; Thaddeus S Stappenbeck; G Alexander Patterson; Richard A Pierce; Steven L Brody; Michael J Holtzman
Journal:  J Clin Invest       Date:  2013-08-15       Impact factor: 14.808

10.  IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

Authors:  Mariola Kurowska-Stolarska; Pete Kewin; Grace Murphy; Remo C Russo; Bartosz Stolarski; Cristiana Couto Garcia; Mousa Komai-Koma; Nick Pitman; Yubin Li; Wanda Niedbala; Andrew N J McKenzie; Mauro M Teixeira; Foo Y Liew; Damo Xu
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

View more
  117 in total

Review 1.  Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.

Authors:  Mark Rusznak; R Stokes Peebles
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-02

2.  Alternative splicing of interleukin-33 and type 2 inflammation in asthma.

Authors:  Erin D Gordon; Laura J Simpson; Cydney L Rios; Lando Ringel; Marrah E Lachowicz-Scroggins; Michael C Peters; Agata Wesolowska-Andersen; Jeanmarie R Gonzalez; Hannah J MacLeod; Laura S Christian; Shaopeng Yuan; Liam Barry; Prescott G Woodruff; K Mark Ansel; Karl Nocka; Max A Seibold; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.

Authors:  Chien-Chang Chen; Takao Kobayashi; Koji Iijima; Fan-Chi Hsu; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2017-02-11       Impact factor: 10.793

4.  Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.

Authors:  Elizabeth A Oczypok; Pavle S Milutinovic; John F Alcorn; Anupriya Khare; Lauren T Crum; Michelle L Manni; Michael W Epperly; Adriane M Pawluk; Anuradha Ray; Tim D Oury
Journal:  J Allergy Clin Immunol       Date:  2015-04-28       Impact factor: 10.793

5.  Endogenous IL-33 and Its Autoamplification of IL-33/ST2 Pathway Play an Important Role in Asthma.

Authors:  Jenna M Magat; Joanna L Thomas; Justin P Dumouchel; Fiona Murray; Willis X Li; Jinghong Li
Journal:  J Immunol       Date:  2020-01-27       Impact factor: 5.422

Review 6.  Innate lymphoid cells: major players in inflammatory diseases.

Authors:  Mikaël Ebbo; Adeline Crinier; Frédéric Vély; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2017-08-14       Impact factor: 53.106

7.  Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma.

Authors:  Kevin M Hart; David F Choy; Peter Bradding; Thomas A Wynn; Joseph R Arron
Journal:  Ann Transl Med       Date:  2017-02

8.  Toll-Interacting Protein, Tollip, Inhibits IL-13-Mediated Pulmonary Eosinophilic Inflammation in Mice.

Authors:  Yoko Ito; Niccolette Schaefer; Amelia Sanchez; David Francisco; Rafeul Alam; Richard J Martin; Julie G Ledford; Connor Stevenson; Di Jiang; Liwu Li; Monica Kraft; Hong Wei Chu
Journal:  J Innate Immun       Date:  2018-01-27       Impact factor: 7.349

9.  Long-lived regulatory T cells generated during severe bronchiolitis in infancy influence later progression to asthma.

Authors:  Jason P Lynch; Rhiannon B Werder; Bodie F Curren; Md Al Amin Sikder; Ashik Ullah; Ismail Sebina; Ridwan B Rashid; Vivian Zhang; John W Upham; Geoff R Hill; Raymond J Steptoe; Simon Phipps
Journal:  Mucosal Immunol       Date:  2020-02-17       Impact factor: 7.313

10.  Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.

Authors:  Sucai Liu; Mukesh Verma; Lidia Michalec; Weimin Liu; Anand Sripada; Donald Rollins; James Good; Yoko Ito; HongWei Chu; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2017-04-20       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.